Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics using Luminex® xMAP® technology: a method for developing a custom multiplex single nucleotide polymorphism mutation assay.

Methods in molecular biology (Clifton, N.J.) - 1 Jan 2013

Spierings Gonnie, Dunbar Sherry A

Abstract excerpt

Sequence variations in the human genome can affect the development of diseases and provide markers for the identification of genetic diseases and drug susceptibility. Single Nucleotide Polymorphisms (SNPs), the most abundant sequence variations in the genome, are used in pharmacogenetics as indicators of drug therapy efficacy in individuals and are important road maps in the route to personalized medicine. This...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Mutational Analysis
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Share to Precision Medicine

Source

Identifiers

PMID: 23824852
DOI: 10.1007/978-1-62703-435-7_7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics using Luminex® xMAP® technology: a method for developing a custom multiplex single nucleotide polymorphism mutation assay.PMID 23824852Read ↗

A Multiplex Pharmacogenetics Assay using the MinION Nanopore Sequencing DeviceSemantic proximity Read ↗

High-throughput methods for SNP genotyping.Semantic proximity Read ↗

Enabling large-scale pharmacogenetic studies by high-throughput mutation detection and genotyping technologies.Semantic proximity Read ↗

Technologies for individual genotyping: detection of genetic polymorphisms in drug targets and disease genes.Semantic proximity Read ↗

Genotyping of single nucleotide polymorphisms by primer extension reaction and a dual-analyte bio/chemiluminometric assay.Semantic proximity Read ↗

SNP technologies for drug discovery: a current review.Semantic proximity Read ↗

Genotyping by Multiplexed Sequencing (GMS) Using SNP Markers.Semantic proximity Read ↗

Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection.Semantic proximity Read ↗

Validation of a Large Custom-Designed Pharmacogenomics Panel on an Array Genotyping Platform.Semantic proximity Read ↗

Medium-throughput SNP genotyping using mass spectrometry: multiplex SNP genotyping using the iPLEX® Gold assay.Semantic proximity Read ↗

Proof of concept for multiplex amplicon sequencing for mutation identification using the MinION nanopore sequencer.Semantic proximity Read ↗

High throughput genotyping technologies for pharmacogenomics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.